[DPHARMA] QoQ Quarter Result on 31-Mar-2020 [#1]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
18-May-2020
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2020
Quarter
31-Mar-2020 [#1]
Profit Trend
QoQ- 12.7%
YoY- -6.25%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Quarter Result
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Revenue 134,086 133,772 143,331 158,713 137,755 142,855 145,466 -5.26%
PBT 20,471 18,568 19,391 17,727 13,939 19,768 18,316 7.66%
Tax -4,278 -4,441 -4,662 -4,166 -1,906 -4,909 -4,400 -1.84%
NP 16,193 14,127 14,729 13,561 12,033 14,859 13,916 10.57%
-
NP to SH 16,193 14,127 14,729 13,561 12,033 14,859 13,916 10.57%
-
Tax Rate 20.90% 23.92% 24.04% 23.50% 13.67% 24.83% 24.02% -
Total Cost 117,893 119,645 128,602 145,152 125,722 127,996 131,550 -7.01%
-
Net Worth 642,484 584,565 581,725 540,662 525,364 505,919 503,029 17.63%
Dividend
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Div 42,361 - 3,421 - 34,114 - 6,618 242.80%
Div Payout % 261.60% - 23.23% - 283.51% - 47.56% -
Equity
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Net Worth 642,484 584,565 581,725 540,662 525,364 505,919 503,029 17.63%
NOSH 706,026 706,026 684,383 684,383 684,383 680,106 661,881 4.37%
Ratio Analysis
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
NP Margin 12.08% 10.56% 10.28% 8.54% 8.74% 10.40% 9.57% -
ROE 2.52% 2.42% 2.53% 2.51% 2.29% 2.94% 2.77% -
Per Share
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
RPS 18.99 19.22 20.94 23.19 20.19 21.18 21.98 -9.24%
EPS 2.29 2.03 2.15 1.98 1.76 2.20 2.07 6.93%
DPS 6.00 0.00 0.50 0.00 5.00 0.00 1.00 228.40%
NAPS 0.91 0.84 0.85 0.79 0.77 0.75 0.76 12.69%
Adjusted Per Share Value based on latest NOSH - 684,383
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
RPS 13.94 13.91 14.90 16.50 14.32 14.85 15.12 -5.24%
EPS 1.68 1.47 1.53 1.41 1.25 1.54 1.45 10.26%
DPS 4.40 0.00 0.36 0.00 3.55 0.00 0.69 241.95%
NAPS 0.6679 0.6077 0.6047 0.5621 0.5461 0.5259 0.5229 17.63%
Price Multiplier on Financial Quarter End Date
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Date 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 28/06/19 -
Price 3.38 3.16 1.62 1.39 1.42 1.40 1.37 -
P/RPS 17.80 16.44 7.74 5.99 7.03 6.61 6.23 100.71%
P/EPS 147.37 155.66 75.27 70.15 80.52 63.56 65.16 71.87%
EY 0.68 0.64 1.33 1.43 1.24 1.57 1.53 -41.61%
DY 1.78 0.00 0.31 0.00 3.52 0.00 0.73 80.67%
P/NAPS 3.71 3.76 1.91 1.76 1.84 1.87 1.80 61.60%
Price Multiplier on Announcement Date
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Date 22/02/21 12/11/20 13/08/20 18/05/20 13/02/20 29/11/19 30/08/19 -
Price 3.42 4.04 3.15 1.72 1.64 1.39 1.41 -
P/RPS 18.01 21.02 15.04 7.42 8.12 6.56 6.42 98.28%
P/EPS 149.11 199.01 146.36 86.80 92.99 63.10 67.06 69.94%
EY 0.67 0.50 0.68 1.15 1.08 1.58 1.49 -41.16%
DY 1.75 0.00 0.16 0.00 3.05 0.00 0.71 81.96%
P/NAPS 3.76 4.81 3.71 2.18 2.13 1.85 1.86 59.53%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment